专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US10166686B1 Portable, self-contained, ready-to-use, sterile enclosure for filling sterile products 有权
公开(公告)号：US10166686B1
公开(公告)日：2019-01-01
申请号：US15732595
申请日：2017-11-30
申请人： Jasbir Dhanjal , Kirk McMullin
发明人： Jasbir Dhanjal , Kirk McMullin
IPC分类号： B65B3/00 , B25J21/02 , B65B31/02 , B65B55/02 , A61M5/178 , B67C3/02 , A61J1/14 , B67C7/00 , A61J1/03
摘要： A portable, self-contained, ready-to-use, sterile enclosure used in the filling of small quantities of sterile products. Particularly, an enclosure that contains the vials or bottles to be filled, as well as all necessary fittings and filters integrated with the assembled apparatus, and which as a total assembly can be reduced to a small package size, thereby enabling the entire assembly to be sterilized remotely in one step by gamma irradiation or ethylene oxide gas. The design of the enclosure assembly further enables shipment to the end user in sterile ready-to-use condition, and allows the end user to perform sterile filling within the enclosure without the need for any aseptic connections or further equipment sterilization steps.

2. 发明申请

US20120195972A1 OPHTHALMIC FORMULATIONS AND USES THEREOF 有权
标题翻译：眼底配方及其用途
公开(公告)号：US20120195972A1
公开(公告)日：2012-08-02
申请号：US13369452
申请日：2012-02-09
申请人： Mark Abelson , Kirk McMullin , Angel Padilla
发明人： Mark Abelson , Kirk McMullin , Angel Padilla
IPC分类号： A61K33/42 , A61P41/00 , A61P27/06 , B65D69/00 , A61P37/00 , A61P31/12 , A61P31/04 , A61P27/02 , A61P29/00
CPC分类号： A61K9/48 , A61K9/0012 , A61K9/0048 , A61K9/10 , A61K31/195 , A61K31/496 , A61K31/573 , A61K31/7034 , A61K31/7036 , A61K33/14 , A61K33/42 , A61K45/06 , A61K47/00 , A61K2300/00
摘要： Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation for the treatment of changes in the normal eye condition. The invention also includes methods of treating patient's having an ophthalmic disease, injury or disorder, utilizing the compositions or formulations. Also provided are kits comprising the compositions or formulations and a means of applying the compositions or formulation to the patient's eyes.
摘要翻译：本发明提供了适用于患者眼睛的组合物或制剂，其利用局部眼科可接受的制剂，其包含治疗有效量的眼科活性抗微生物剂和眼科活性抗炎或甾族化合物与眼用制剂中的血清电解质的生理水平的组合用于治疗正常眼睛状况的变化。本发明还包括利用组合物或制剂治疗患有眼科疾病，损伤或病症的患者的方法。还提供了包含组合物或制剂的试剂盒以及将组合物或制剂施用于患者眼睛的方法。

3. 发明授权

US08372814B2 Ophthalmic formulations and uses thereof 有权
标题翻译：眼用制剂及其用途
公开(公告)号：US08372814B2
公开(公告)日：2013-02-12
申请号：US11146652
申请日：2005-06-07
申请人： Mark Abelson , Kirk McMullin
发明人： Mark Abelson , Kirk McMullin
IPC分类号： A01N43/04 , A61K31/70
CPC分类号： A61K31/7036 , A61K31/195 , A61K31/496 , A61K31/573 , A61K31/7034 , A61K33/14 , A61K33/42 , A61K45/06 , A61K2300/00
摘要： Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation for the treatment of changes in the normal eye condition. The invention also includes methods of treating patient's having an ophthalmic disease, injury or disorder, utilizing the compositions or formulations. Also provided are kits comprising the compositions or formulations and a means of applying the compositions or formulation to the patient's eyes.
摘要翻译：本发明提供了适用于患者眼睛的组合物或制剂，其利用局部眼科可接受的制剂，其包含治疗有效量的眼科活性抗微生物剂和眼科活性抗炎或甾族化合物与眼用制剂中的血清电解质的生理水平的组合用于治疗正常眼睛状况的变化。本发明还包括利用组合物或制剂治疗患有眼科疾病，损伤或病症的患者的方法。还提供了包含组合物或制剂的试剂盒以及将组合物或制剂施用于患者眼睛的方法。

4. 发明授权

US08748402B2 Ophthalmic formulations and uses thereof 有权
标题翻译：眼用制剂及其用途
公开(公告)号：US08748402B2
公开(公告)日：2014-06-10
申请号：US13369452
申请日：2012-02-09
申请人： Mark Abelson , Kirk McMullin , Angel Padilla
发明人： Mark Abelson , Kirk McMullin , Angel Padilla
IPC分类号： A01N43/04 , A61K31/70 , A61K9/48
CPC分类号： A61K9/48 , A61K9/0012 , A61K9/0048 , A61K9/10 , A61K31/195 , A61K31/496 , A61K31/573 , A61K31/7034 , A61K31/7036 , A61K33/14 , A61K33/42 , A61K45/06 , A61K47/00 , A61K2300/00
摘要： Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation for the treatment of changes in the normal eye condition. The invention also includes methods of treating patient's having an ophthalmic disease, injury or disorder, utilizing the compositions or formulations. Also provided are kits comprising the compositions or formulations and a means of applying the compositions or formulation to the patient's eyes.
摘要翻译：本发明提供了适用于患者眼睛的组合物或制剂，其利用局部眼科可接受的制剂，其包含治疗有效量的眼科活性抗微生物剂和眼科活性抗炎或甾族化合物与眼用制剂中的血清电解质的生理水平的组合用于治疗正常眼睛状况的变化。本发明还包括利用组合物或制剂治疗患有眼科疾病，损伤或病症的患者的方法。还提供了包含组合物或制剂的试剂盒以及将组合物或制剂施用于患者眼睛的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式